Freestone Capital Holdings, LLC Edwards Lifesciences Corp Transaction History

Freestone Capital Holdings, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$86.5 - $128.27 $275,243 - $408,155	-3,182 Reduced 53.23%	2,796 $266,000
Q1 2022 May 12, 2022	BUY	$101.96 - $128.34 $101,552 - $127,826	996 Added 19.99%	5,978 $704,000
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $105,944 - $130,157	996 Added 24.99%	4,982 $645,000
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $91,795 - $109,493	892 Added 28.83%	3,986 $451,000
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $14,420 - $18,018	172 Added 5.89%	3,094 $320,000
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $67,350 - $77,613	856 Added 41.43%	2,922 $244,000
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $38,999 - $49,629	544 Added 35.74%	2,066 $188 Million
Q3 2020 Nov 06, 2020	BUY	$67.19 - $87.44 $102,263 - $133,083	1,522 New	1,522 $121,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Freestone Capital Holdings, LLC with notifications on news.